Buy or sell Compass Pathways stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
2020 IPO
Compass Pathways Stock
Compass Pathways will be testing the active ingredient of magic mushrooms, psylocybin, as a treatment for depression.
About Compass Pathways Stock
Compass Pathways will be testing the active ingredient of magic mushrooms, psylocybin, as a treatment for depression.
Funding History
| January 2017 | $4.0M |
|---|
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
